Skip to content
10-Q

Quarterly Report

Immuneering Corporation IMRX

0001790340-25-000104

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Jun 30, 2025 35.99M sh
Shares Diluted Q2 2025 · Jun 30, 2025 35.76M sh
Shares Diluted Q2 2025 · Jun 30, 2024 29.65M sh
Shares Diluted Q2 2025 · Jun 30, 2024 29.51M sh
Capex Q2 2025 · Jun 30, 2025 $11.06K
Capex Q2 2025 · Jun 30, 2024 $70.25K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$23.53M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$27.02M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $26.36M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $36.14M
Stockholders Equity Q2 2025 · Jun 30, 2025 $28.94M
Stockholders Equity Q2 2025 · Mar 31, 2025 $41.84M
Stockholders Equity Q2 2025 · Dec 31, 2024 $41.39M
Stockholders Equity Q2 2025 · Jun 30, 2024 $66.31M
Stockholders Equity Q2 2025 · Mar 31, 2024 $78.72M
Stockholders Equity Q2 2025 · Dec 31, 2023 $90.58M
Current Liabilities Q2 2025 · Jun 30, 2025 $7.49M
Current Liabilities Q2 2025 · Dec 31, 2024 $7.5M
Total Liabilities Q2 2025 · Jun 30, 2025 $11.12M
Total Liabilities Q2 2025 · Dec 31, 2024 $11.33M
Current Assets Q2 2025 · Jun 30, 2025 $27.73M
Current Assets Q2 2025 · Dec 31, 2024 $39.59M
Total Assets Q2 2025 · Jun 30, 2025 $40.06M
Total Assets Q2 2025 · Dec 31, 2024 $52.71M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.40
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.82
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.47
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.96
Eps Basic Q2 2025 · Jun 30, 2025 −$0.40
Eps Basic Q2 2025 · Jun 30, 2025 −$0.82
Eps Basic Q2 2025 · Jun 30, 2024 −$0.47
Eps Basic Q2 2025 · Jun 30, 2024 −$0.96
Sga Expense Q2 2025 · Jun 30, 2025 $4.3M
Sga Expense Q2 2025 · Jun 30, 2025 $8.3M
Sga Expense Q2 2025 · Jun 30, 2024 $4.25M
Sga Expense Q2 2025 · Jun 30, 2024 $8.37M
Rd Expense Q2 2025 · Jun 30, 2025 $10.45M
Rd Expense Q2 2025 · Jun 30, 2025 $21.93M
Rd Expense Q2 2025 · Jun 30, 2024 $10.65M
Rd Expense Q2 2025 · Jun 30, 2024 $21.85M
Net Income Q2 2025 · Jun 30, 2025 −$14.43M
Net Income Q2 2025 · Jun 30, 2025 −$29.48M
Net Income Q2 2025 · Mar 31, 2025 −$15.05M
Net Income Q2 2025 · Jun 30, 2024 −$14.08M
Net Income Q2 2025 · Jun 30, 2024 −$28.39M
Net Income Q2 2025 · Mar 31, 2024 −$14.31M
Operating Income Q2 2025 · Jun 30, 2025 −$14.76M
Operating Income Q2 2025 · Jun 30, 2025 −$30.24M
Operating Income Q2 2025 · Jun 30, 2024 −$14.91M
Operating Income Q2 2025 · Jun 30, 2024 −$30.24M